222 related articles for article (PubMed ID: 22021636)
41. Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.
Magnan R; Masri B; Escrieut C; Foucaud M; Cordelier P; Fourmy D
J Biol Chem; 2011 Feb; 286(8):6707-19. PubMed ID: 21156802
[TBL] [Abstract][Full Text] [Related]
42. SRC regulates constitutive internalization and rapid resensitization of a cholecystokinin 2 receptor splice variant.
Chao C; Ives KL; Goluszko E; Kolokoltsov AA; Davey RA; Townsend CM; Hellmich MR
J Biol Chem; 2005 Sep; 280(39):33368-73. PubMed ID: 16079138
[TBL] [Abstract][Full Text] [Related]
43. Valine-286 residue in the third intracellular loop of the cholecystokinin 2 receptor exerts a pivotal role in cholecystokinin 2 receptor mediated intracellular signal transduction in human colon cancer cells.
Yu HG; Schäfer H; Mergler S; Müerköster S; Cramer T; Höcker M; Herzig KH; Schmidt WE; Schmitz F
Cell Signal; 2005 Dec; 17(12):1505-15. PubMed ID: 15951156
[TBL] [Abstract][Full Text] [Related]
44. A fluorescent ligand-binding alternative using Tag-lite® technology.
Zwier JM; Roux T; Cottet M; Durroux T; Douzon S; Bdioui S; Gregor N; Bourrier E; Oueslati N; Nicolas L; Tinel N; Boisseau C; Yverneau P; Charrier-Savournin F; Fink M; Trinquet E
J Biomol Screen; 2010 Dec; 15(10):1248-59. PubMed ID: 20974902
[TBL] [Abstract][Full Text] [Related]
45. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor.
Desai AJ; Mechin I; Nagarajan K; Valant C; Wootten D; Lam PCH; Orry A; Abagyan R; Nair A; Sexton PM; Christopoulos A; Miller LJ
Mol Pharmacol; 2019 Mar; 95(3):245-259. PubMed ID: 30591538
[TBL] [Abstract][Full Text] [Related]
46. Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.
Jang JY; Kim SW; Ku JL; Park YH; Park JG
World J Gastroenterol; 2005 Feb; 11(6):803-9. PubMed ID: 15682471
[TBL] [Abstract][Full Text] [Related]
47. Cholecystokinin (CCK) stimulates aldosterone secretion from human adrenocortical cells via CCK2 receptors coupled to the adenylate cyclase/protein kinase A signaling cascade.
Mazzocchi G; Malendowicz LK; Aragona F; Spinazzi R; Nussdorfer GG
J Clin Endocrinol Metab; 2004 Mar; 89(3):1277-84. PubMed ID: 15001623
[TBL] [Abstract][Full Text] [Related]
48. Membrane cholesterol depletion from live cells enhances the function of human serotonin(1A) receptors.
Prasad R; Paila YD; Jafurulla M; Chattopadhyay A
Biochem Biophys Res Commun; 2009 Nov; 389(2):333-7. PubMed ID: 19723504
[TBL] [Abstract][Full Text] [Related]
49. Are specific nonannular cholesterol binding sites present in G-protein coupled receptors?
Paila YD; Tiwari S; Chattopadhyay A
Biochim Biophys Acta; 2009 Feb; 1788(2):295-302. PubMed ID: 19111523
[TBL] [Abstract][Full Text] [Related]
50. Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.
Miller LJ; Desai AJ
Trends Endocrinol Metab; 2016 Sep; 27(9):609-619. PubMed ID: 27156041
[TBL] [Abstract][Full Text] [Related]
51. Lack of ghrelin secretion in response to fasting in cholecystokinin-A (-1), -B (-2) receptor-deficient mice.
Sakurai C; Ohta M; Kanai S; Uematsu H; Funakoshi A; Miyasaka K
J Physiol Sci; 2006 Dec; 56(6):441-7. PubMed ID: 17134539
[TBL] [Abstract][Full Text] [Related]
52. Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function.
Whited KL; Thao D; Lloyd KC; Kopin AS; Raybould HE
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G156-62. PubMed ID: 16574983
[TBL] [Abstract][Full Text] [Related]
53. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
[TBL] [Abstract][Full Text] [Related]
54. Permanent Photodynamic Cholecystokinin 1 Receptor Activation: Dimer-to-Monomer Conversion.
Jiang WY; Li Y; Li ZY; Cui ZJ
Cell Mol Neurobiol; 2018 Aug; 38(6):1283-1292. PubMed ID: 29869099
[TBL] [Abstract][Full Text] [Related]
55. Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor.
Hadac EM; Dawson ES; Darrow JW; Sugg EE; Lybrand TP; Miller LJ
J Med Chem; 2006 Feb; 49(3):850-63. PubMed ID: 16451051
[TBL] [Abstract][Full Text] [Related]
56. An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway.
Vatinel S; Ferrand A; Lopez F; Kowalski-Chauvel A; Estève JP; Fourmy D; Dufresne M; Seva C
Biochim Biophys Acta; 2006 Oct; 1763(10):1098-107. PubMed ID: 16963136
[TBL] [Abstract][Full Text] [Related]
57. Permanent Photodynamic Activation of the Cholecystokinin 2 Receptor.
Tang WZ; Cui ZJ
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033232
[TBL] [Abstract][Full Text] [Related]
58. Structures of the human cholecystokinin 1 (CCK1) receptor bound to Gs and Gq mimetic proteins provide insight into mechanisms of G protein selectivity.
Mobbs JI; Belousoff MJ; Harikumar KG; Piper SJ; Xu X; Furness SGB; Venugopal H; Christopoulos A; Danev R; Wootten D; Thal DM; Miller LJ; Sexton PM
PLoS Biol; 2021 Jun; 19(6):e3001295. PubMed ID: 34086670
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the cellular and molecular mechanisms of trophic action of a misspliced form of the type B cholecystokinin receptor present in colon and pancreatic cancer.
Cheng ZJ; Harikumar KG; Ding WQ; Holicky EL; Miller LJ
Cancer Lett; 2005 May; 222(1):95-105. PubMed ID: 15837546
[TBL] [Abstract][Full Text] [Related]
60. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
